ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ベタヒスチン塩酸塩

Betahistine Hydrochloride

HCID 68643
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
5579-84-0
標準SMILES
CNCCc1ccccn1.Cl.Cl
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
分子式
C8H14Cl2N2
平均分子量
209.11 g/mol
単同位体質量
208.0534038

概要

Betahistine Hydrochloride is the hydrochloride salt form of betahistine, a histamine analog with weak histamine H1 agonistic and more potent histamine H3 antagonistic properties. Upon intranasal administration, betahistine binds to histamine H1 and H3 receptors and exerts its agonistic and antagonistic actions locally and centrally. This promotes cochlear, vestibular and cerebral blood flow, decreases neuronal firing in the vestibular nuclei and increases histamine synthesis and release in the brain which facilitates vestibular compensation. Increased blood flow around the inner ear reduces the amount of fluid in the inner ear and may alleviate vertigo, tinnitus, and hearing loss.

名称と識別子

優先名称
Betahistine Hydrochloride
IUPAC
N-methyl-2-pyridin-2-ylethanamine;dihydrochloride
現地名
ベタヒスチン塩酸塩
英語名
Betahistine dihydrochloride
分子式
C8H14Cl2N2
分子量
209.12

名称と別名

Betahistine hydrochlorideBetahistine HClSercBetaserc2-Pyridineethanamine, N-methyl-, dihydrochloride2-(2-(Methylamino)ethyl)pyridine dihydrochloride49K58SMZ7UNSC-757397DTXSID102043552-[2-(Methylamino)ethyl]pyridine dihydrochlorideSerc-8Serc-16
名称をさらに表示
ミクロセルベタヒスチン二塩酸塩ベタヒスチン塩酸塩N-メチルピリジン-2-エタンアミン·2塩酸塩2-(2-メチルアミノエチル)ピリジン·2塩酸塩塩酸ベタヒスチンN-メチル-2-ピリジンエタンアミン·2塩酸塩バソモタールセルク2-〔2-(メチルアミノ)エチル〕ピリジン二塩酸塩ベタヒスチン 二塩酸塩ベタヒスチン 塩酸塩N-メチルピリジン-2-エタンアミン・2塩酸塩2-(2-メチルアミノエチル)ピリジン・2塩酸塩N-メチル-2-ピリジンエタンアミン・2塩酸塩β-ヒスチン二塩酸塩Betahistine Di HClPT-9SinMenierBetahistineHClBETASTINE DI HCLBetahistine 2 hcl
RefChem:567992DTXCID10126846226-966-5Betahistine dihydrochloride5579-84-0Betahistine 2HClMicroserAntivom

物性

構造計算による物性

極性表面積
24.9 Ų
水素結合供与体数
3
水素結合受容体数
2
回転可能結合数
3
重原子数
12
形式電荷
0
複雑度
83.3

物理化学的性質

融点
150 · 150-154 °C
貯蔵温度
2 · 2-8°C
溶解性
水に非常に溶けやすく、エタノール (96%) に溶け、2-プロパノールにはほとんど溶けない。
外見
粉
色
ペールイエロー
安定性
吸湿性
InChI
InChI=1S/C8H12N2.2ClH/c1-9-7-5-8-4-2-3-6-10-8;;/h2-4,6,9H,5,7H2,1H3;2*1H
InChIKey
XVDFMHARQUBJRE-UHFFFAOYSA-N
SMILES
C1(CCNC)=NC=CC=C1.Cl.Cl
CAS データベース
5579 · 5579-84-0(CAS DataBase Reference)

化学的性質

化学的特性white to light yellow crystalline powder

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 5 件

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Warning

H315 (94.5%): Causes skin irritation [Warning Skin corrosion/irritation]

P261, P264, P264+P265, P271, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Other Safety InformationIMAP assessments - 2-Pyridineethanamine, N-methyl-, dihydrochloride: Environment tier I assessment
Hazard Classes and CategoriesSkin Irrit. 2 (94.5%)

安全データ

wgk
3
rtecs
UT2969000
hs_code
29333990
safety_code
24/25
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

MeSH Pharmacological Classification · 2 件

Drugs used to cause dilation of the blood vessels.

Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.

応用分野 · 3 件

説明Betahistine dihydrochloride (BH.2HCl) is an orally active histamine analog which has been used to control vertigo, lack of hearing and tinnitus related to Ménière’s disease. The mechanism of BH.2HCl is to reduce the pressure of the membranous labyrinth that results in enhancement of the microvasculature circulation and improves the signs of Ménière’s disease. Peroral administration undergoes extensive first-pass metabolism and gastric irritation in patients with peptic ulcer. In treatment of vertigo, a uniform and constant supply of drug is required in order to maintain steady-state concentration of the drug in the body. Unfortunately, BH.2HCl possesses a short half-life of about 3–4 h and requires frequent administration of the drug,12–15 thereby making it an ideal candidate for controlled release preparations.

使用Betahistine is belongs to a group of medications used to treat vertigo associated with Ménière's disease. Vertigo is a condition that causes sufferers to have a sensation of rotation or movement of themselves or their surroundings. Ménière's disease is a disorder of the inner ear that causes vertigo in addition to symptoms such as ringing in the ears, headache, and loss of hearing.Betahistine is used to reduce the number of episodes of vertigo associated with Ménière's disease. It is believed to work by decreasing the pressure in the ear. This pressure is believed to contribute to the sense of dizziness, nausea, and ringing in the ears and hearing loss that people with Ménière's disease experience.

一般的な説明Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

上流・下流製品情報

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
5579-84-0
PubChem CID
68643
DTXSID
DTXSID10204355
ChEMBL
CHEMBL1446813
UNII
49K58SMZ7U
EC Number
226-966-5

下流製品

N-Methyl-N,N-bis(2-pyridylethyl)amine